INSIGHTS ON DRUG DEVELOPMENT

• NanoImprove The Performance Of Your Formulations

  Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

• N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit

  Discover a company that tripled productivity and cut costs by optimizing its seed train process to achieve major gains without infrastructure expansion.

• Non Animal Origin Squalene For High-Risk Applications

  Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.

• 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay

  Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

• Expanding Translational Research Concepts With Genedata Profiler

  11/26/2024

  The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.

• Optimizing Pediatric Product Development For Commercialization Success

  4/10/2024

  Ensuring medication adherence in pediatric patients presents challenges for pharmacotherapy. Explore various dosing solutions and learn how to streamline your pediatric development journey.

• Biofluorescent Particle Counters Are Gaining Momentum

  4/28/2025

  The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.

• Column Selection For RPLC-UV Impurity Analysis

  7/17/2025

  Explore the performance of four column chemistries for RPLC-UV impurity analysis of liraglutide and semaglutide, which offers practical guidance for method development in peptide-based therapeutics.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.